Get a Second Opinion | NYU Langone Health
Request a second opinion about diagnosis or treatment for an orthopedic condition from an NYU Langone orthopedic specialist.
Gift Shop at NYU Langone Hospital—Brooklyn | NYU Langone Health
The Gift Shop at NYU Langone Hospital—Brooklyn sells everyday and specialty items.
Gift Shop at NYU Langone Hospital—Long Island | NYU Langone Health
We use cookies and similar tools to give you the best website experience. By using our site, you accept ...
Glaucoma | NYU Langone Health
NYU Langone doctors manage glaucoma, a degenerative eye condition, to slow or stop its progression and preserve vision.
Glioma & Astrocytoma | NYU Langone Health
At NYU Langone’s Perlmutter Cancer Center, we treat gliomas, glioblastomas, and astrocytomas, types of sometimes life-threatening brain cancer.
Glomerular Disease Program | NYU Langone Health
Doctors at the Glomerular Disease Program provide care for children at Hassenfeld Children’s Hospital at NYU Langone.
Glomerulonephritis in Children | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital at NYU Langone diagnose and treat glomerulonephritis, a condition that causes kidney inflammation.
Gluten-Free Diet for Celiac Disease in Children | NYU Langone Health
Specialists at Hassenfeld Children’s Hospital at NYU Langone help children with celiac disease adapt to a gluten-free diet.
Glycemic and Cardiometabolic Biomarker improvements associated with reduction in air pollution exposure
In this research, we will conduct a double-blind, sham-controlled, randomized trial to examine the glycemic and cardiometabolic impact of air pollution exposure reduction using home portable air cleaners (PACs) in a cohort of 142 adult with prediabetes. This study will not evaluate the PAC or sham as medical devices in the context of this research; rather, the PAC and sham will be used per their commercialized indication as tools to standardize the conditions in order to measure the glycemic and cardiometabolic impact of reduced air pollution exposure.
Goal-Directed Cardiopulmonary Resuscitation in Cardiac Arrest Using a Novel Physiological Target: A Pilot Mechanistic Randomized Control Trial
The proposed study is a single-center, randomized controlled pilot trial of adults who suffer in-hospital cardiac arrests. Using cerebral oxygenation and end-tidal carbon dioxide physiological targets to predict survival and neurological outcome, the impact of physiological-feedback CPR will be assessed. 150 adult patients who have a cardiac arrest event at NYU Tisch Hospital will be randomized to one of two treatment groups: (1) Physiological-Feedback CPR or (2) Non-Physiological (Audiovisual) Feedback CPR.